Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
02.11.20
€8.00
04.11.21
-
16.11.20

Could be very worthwhile Investment >20% year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.15
02.11.20
€13.00
04.11.21
-4.96%
05.11.21

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.20
02.11.20
€5.00
02.11.20
-0.74%
02.11.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.08
02.11.20
-
04.11.21
-25.32%
07.11.20

Probably not worthwhile Investment
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€267.50
27.10.20
€300.00
31.10.20
8.41%
31.10.20

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€8.90
27.10.20
-
04.11.21
-24.99%
15.07.21

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€8.90
26.10.20
-
27.10.20
0.00%
27.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€8.95
26.10.20
-
26.10.20
-0.56%
26.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€9.25
26.10.20
-
26.10.20
-3.24%
26.10.20

Risky Investment
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€25.77
21.10.20
-
04.11.21
-36.63%
05.11.21

Risky Investment
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.28
21.10.20
€6.00
04.11.21
348.60%
05.11.21

Could be worthwhile Investment >10% per year
buy
Misonix Inc.

Start price
Target price
Perf. (%)
€10.30
21.10.20
€12.00
02.11.20
-7.28%
02.11.20

Could be worthwhile Investment >10% per year
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€9.65
19.10.20
€12.00
02.11.20
12.95%
02.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€12.20
19.10.20
€15.00
02.11.20
-6.56%
02.11.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€16.30
19.10.20
€20.00
02.11.20
-0.61%
02.11.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
19.10.20
€10.00
02.11.20
-
02.11.20

Could be very worthwhile Investment >20% year
buy
PDL BioPharma Inc.

Start price
Target price
Perf. (%)
€2.11
06.10.20
-
04.11.21
5.22%
05.11.21

Could be worthwhile Investment >10% per year
High dividend yield expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.70
05.10.20
€15.00
19.10.20
-17.52%
19.10.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€10.70
05.10.20
€13.00
19.10.20
14.02%
19.10.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€15.70
05.10.20
€20.00
19.10.20
3.82%
19.10.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
05.10.20
€1.00
19.10.20
-
19.10.20

Could be very worthwhile Investment >20% year
buy
AMAG Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.98
01.10.20
€14.00
13.10.20
3.42%
13.10.20

Risky Investment
Inovio Pharma

Start price
Target price
Perf. (%)
€13.60
23.09.20
-
26.10.20
-31.99%
26.10.20

Risky Investment
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.17
21.09.20
€12.00
02.11.20
-24.15%
02.11.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.92
20.09.20
-
04.11.21
6.78%
05.11.21

Could be worthwhile Investment >10% per year
Very low/no dividend yield expected